Tuesday 13 May 2025

Pharma & Biotech Start-up & Scale-up News

Featured

Boundless Bio
Boundless Bio is a biotechnology company seeking to develop novel therapies to treat cancer.
Pharmaceutical
Lexicon Pharma soars as it licenses LX9851 to Novo Nordisk
28 March 2025
Pharmaceutical
Lexicon pivots back to pipeline after FDA rejection
25 November 2024

Latest Ones To Watch News

Biotechnology
Paul Conrad joins Aeta Therapeutics as chief business and financial officer
12 May 2025
Pharmaceutical
Pharmacosmos assumes global rights to lerociclib outside Asia-Pacific
12 May 2025
Pharmaceutical
Shine Technologies to acquire Lantheus' SPECT division
12 May 2025
More ones to watch news >
Reset all filters
Refine Search
Cidara Therapeutics
Cidara Therapeutics
Halda Therapeutics
Halda Therapeutics
Opthea
OncoZenge
Axsome Therapeutics
Soleno Therapeutics
GAIA
Alligator Bioscience
Pliant Therapeutics
Nuvation Bio
Enanta Pharmaceuticals
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics
Jacobio Pharma


Today's issue

Roche sets sights on Shanghai with major eye drug plant
Biotechnology
Roche sets sights on Shanghai with major eye drug plant
12 May 2025
Pharmaceutical
Almirall up 10% on impressive financials
12 May 2025
Pharmaceutical
Minghui hands rights for cancer drug to Qilu in $38 million pact
12 May 2025
Biotechnology
BioMarin presents new data for Voxzogo
12 May 2025
Pharmaceutical
Shionogi inks new hearing loss research deal with Cilcare
12 May 2025
Biotechnology
J&J’s IL-23-blocking oral peptide icotrokinra shows further promise
12 May 2025
Biotechnology
Paul Conrad joins Aeta Therapeutics as chief business and financial officer
12 May 2025

Company Spotlight

Boundless Bio is a biotechnology company seeking to develop novel therapies to treat cancer.




Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze